Literature DB >> 27227983

Complications After Surgical Management of Proximal Femoral Metastasis: A Retrospective Study of 417 Patients.

Stein J Janssen1, Joost T P Kortlever, John E Ready, Kevin A Raskin, Marco L Ferrone, Francis J Hornicek, Santiago A Lozano-Calderon, Joseph H Schwab.   

Abstract

BACKGROUND: Proximal femoral fractures resulting from metastatic disease often require surgical management. Few studies have compared surgical techniques, and physicians' preferred strategies vary. This study compared revision and complication rates among surgical strategies.
METHODS: The study consisted of a retrospective review of electronic medical records of 417 consecutive patients with proximal femoral metastasis or multiple myeloma who underwent intramedullary nailing (n = 302), endoprosthetic reconstruction (n = 70), and open reduction and internal fixation (n = 45) between 1999 and 2014 at two orthopaedic oncology centers. Primary outcome measures were revisions and 30-day systemic complications. Secondary outcome measures were total estimated blood loss, anesthesia time, duration of hospital admission, and 30-day survival.
RESULTS: Revision rates did not differ between strategies (5.3% after intramedullary nailing, 11% after endoprosthetic reconstruction, and 13% after open reduction and internal fixation; P = 0.134). When reasons for revision were assessed separately, fixation failure was most common after open reduction and internal fixation (13% versus 3.0% after intramedullary nailing and none after endoprosthetic reconstruction; P < 0.001), whereas deep infection was most common after endoprosthetic reconstruction (8.6% versus 2.0% after intramedullary nailing and none after open reduction and internal fixation; P = 0.010). Overall systemic complication rates did not differ between strategies (8.3% after intramedullary nailing, 14% after endoprosthetic reconstruction, and 11% after open reduction and internal fixation; P = 0.268).
CONCLUSION: Implant-specific complications and their timing should be considered in the choice of surgical strategy. Analysis of secondary outcomes and risk factors for systemic complications could aid in surgical decision making. LEVEL OF EVIDENCE: Therapeutic Level III.

Entities:  

Mesh:

Year:  2016        PMID: 27227983     DOI: 10.5435/JAAOS-D-16-00043

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  12 in total

1.  What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?

Authors:  Julie J Willeumier; Mustafa Kaynak; Peer van der Zwaal; Sven A G Meylaerts; Nina M C Mathijssen; Paul C Jutte; Panagiotis Tsagozis; Rikard Wedin; Michiel A J van de Sande; Marta Fiocco; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

Review 2.  [Metastatic disease in long bones : Review of surgical treatment options].

Authors:  Franz Liska; Philipp Schmitz; Norbert Harrasser; Peter Prodinger; Hans Rechl; Rüdiger von Eisenhart-Rothe
Journal:  Unfallchirurg       Date:  2018-01       Impact factor: 1.000

3.  Body composition predictors of mortality in patients undergoing surgery for long bone metastases.

Authors:  Olivier Q Groot; Michiel E R Bongers; Colleen G Buckless; Peter K Twining; Neal D Kapoor; Stein J Janssen; Joseph H Schwab; Martin Torriani; Miriam A Bredella
Journal:  J Surg Oncol       Date:  2022-01-13       Impact factor: 2.885

4.  Prosthesis or osteosynthesis for the treatment of a pathological hip fracture? A nationwide registry-based cohort study.

Authors:  Panagiotis Tsagkozis; Jessica Ehne; Rikard Wedin; Margareta Hedström
Journal:  J Bone Oncol       Date:  2021-06-14       Impact factor: 4.072

5.  No consensus on implant choice for oligometastatic disease of the femoral head and neck.

Authors:  Taylor J Reif; Patrick K Strotman; Stephanie A Kliethermes; Benjamin J Miller; Lukas M Nystrom
Journal:  J Bone Oncol       Date:  2018-02-27       Impact factor: 4.072

6.  Cemented versus cementless megaprosthesis in proximal femur metastatic disease: A systematic review.

Authors:  Maria Serena Oliva; Raffaele Vitiello; Michele Cauteruccio; Elisa Pesare; Giuseppe Rovere; Cesare Meschini; Francesco Liuzza; Giulio Maccauro; Antonio Ziranu
Journal:  Orthop Rev (Pavia)       Date:  2020-06-26

7.  Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries.

Authors:  Haochen Mou; Zhan Wang; Wenkan Zhang; Guoqi Li; Hao Zhou; Eloy Yinwang; Fangqian Wang; Hangxiang Sun; Yucheng Xue; Zenan Wang; Tao Chen; Xupeng Chai; Hao Qu; Peng Lin; Wangsiyuan Teng; Binghao Li; Zhaoming Ye
Journal:  Front Oncol       Date:  2021-09-17       Impact factor: 6.244

8.  Body Composition Predictors of Adverse Postoperative Events in Patients Undergoing Surgery for Long Bone Metastases.

Authors:  Peter K Twining; Olivier Q Groot; Colleen G Buckless; Neal D Kapoor; Michiel E R Bongers; Stein J Janssen; Joseph H Schwab; Martin Torriani; Miriam A Bredella
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-03-09

9.  Thirty-day Postoperative Complications After Surgery For Metastatic Long Bone Disease Are Associated With Higher Mortality at 1 Year.

Authors:  Bas J J Bindels; Quirina C B S Thio; Kevin A Raskin; Marco L Ferrone; Santiago A Lozano Calderón; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

10.  Modified Unipolar Hemiarthroplasty for the Treatment of Metastatic Lesions of Proximal Femur with Pathological Fractures: Case Series of Six Patients.

Authors:  C Y Lim; S Mat-Hassan; M Awang; M F Md-Ariff; M A Hau-Abdullah
Journal:  Malays Orthop J       Date:  2019-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.